(Q46853430)

English

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial

scientific article published in April 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

quality of life

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

object named as

Anthony E Lang

6

0 references

Connie Fernández-Cid Marras

1

object named as

Connie Marras

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

Caroline M Tanner

4

object named as

Caroline M Tanner

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

Parkinson Study Group DATATOP Investigators

7

object named as

Parkinson Study Group DATATOP Investigators

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

5

object named as

Gary Naglie

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

author name string

Michael P McDermott

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

23

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

653-9; quiz 776

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

The relative health related quality of life of veterans with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Health related quality of life in Parkinson's disease: a prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Factors impacting on quality of life in Parkinson's disease: results from an international survey

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

What contributes to quality of life in patients with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Linking clinical variables to health-related quality of life in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Development and testing of the Parkinson's disease quality of life scale

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lo

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Changes in motor subtype and risk for incident dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.21853

21 January 2018

Identifiers

10.1002/MDS.21853

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18076084

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46853430&oldid=2134745012"